Reimbursement
A spokesman confirmed Nevada and Virginia would be among the states where it will retain a presence. In the past week, UnitedHealthcare said it would leave Georgia, Michigan, and Arkansas.
Bon Secours Health System and Eugene Y. Chang, MD, one of the system's surgical oncologists, will pay $400,000 to settle civil fraud allegations leveled against them in a whistleblower lawsuit filed by a former Bon Secours practice manager and one of Chang's former colleagues, the Department of Justice announced Monday.
UnitedHealth Group is exiting the Affordable Care Act markets in Michigan, Oklahoma and other areas citing a lack of profitability.
A single, coordinated approach to performance reporting is needed to make promised Medicare payment reforms work, the American Medical Association and other physician groups are expected to tell lawmakers Tuesday morning during a Subcommittee on Health hearing on Capitol Hill.
If UnitedHealthcare follows through on its threat to quit the health insurance marketplaces in 2017, more than 1 million consumers would be left with a single health plan option, an analysis released Monday forecasted.
Rule affects 3,330 acute care hospitals, 430 long-term care hospitals.
The Supreme Court will hear oral arguments Tuesday in what could be a precedent-setting case stemming from the death of a Massachusetts teen after treatment at a Universal Health Services-owned facility. The case, referred to as Universal Health Services v United States ex rel. Escobar, was brought by the teen's parents against Universal Health Services, the largest owner of psychiatric hospitals and clinics in the United States.
The more than 1,500 healthcare providers taking part in the Bundled Payments for Care Improvement initiative may extend their participation in Models 2, 3 and 4 through September 30, 2018, according to the Centers for Medicare and Medicaid Services.
Third-party nonprofits promising scientific and transparent drug value assessments are gaining ground in healthcare, even as many drug manufacturers are challenging their methodologies, according to new research by the Health Research Institute.
Pharmaceutical company Warner Chilcott was sentenced Friday in U.S. District Court in Boston to pay $125 million to resolve criminal and civil liability stemming from the illegal promotion of various drugs including Actonel, Asacol, Atelvia, Doryx, Enablex, Estrace, Loestrin and various formulations of these drugs, the U.S. Attorney's Office announced Friday.